Original articleUse of antibiotic-impregnated cement during hip and knee arthroplasty in the United States
References (26)
- et al.
Role of gentamicin-impregnated cement in total joint arthroplasty
Orthop Clin North Am
(1988) - et al.
Total hip replacement in the previously septic hip
J Bone Joint Surg
(1983) - et al.
Two-stage reimplantation for the salvage of infected total knee arthroplasty
J Bone Joint Surg
(1983) - et al.
Delayed reconstruction for the infected hip implant: a prospective study
Orthop Trans
(1983) - et al.
Total hip arthroplasty in the treatment of adult hips with current or quiescent sepsis
J Bone Joint Surg
(1981) - et al.
Deep infection in Charnley low-friction arthroplasty
J Bone Joint Surg
(1987) - et al.
Management of deep infection of total hip replacement
J Bone Joint Surg
(1981) - et al.
Uber die Depotwirkung einiger antibiotika bei Vermischung mi dem Kunstharz Palacos
Chirurgie
(1970) - et al.
Results of revision for mechanical failure after cemented total hip replacement: 1979 to 1982
J Bone Joint Surg
(1985) - et al.
Deep wound sepsis following total hip arthroplasty
J Bone Joint Surg
(1977)
Antibiotic-impregnated acrylic bone cement
J Bone Joint Surg
The release of gentamicin from polymethyl methacrylate beads: an experimental and pharmacokinetic study
J Bone Joint Surg
Pharmacokinetic study of gentamicin-loaded cement in total hip replacements: comparative effects of varying dosage
J Bone Joint Surg
Cited by (87)
When and How Should I Use Antibiotic Cement in Primary and Revision Joint Arthroplasty?
2022, Journal of ArthroplastyCitation Excerpt :Consequently, it is critical as a surgeon to understand the elution properties of high-dose ALBC to safely and effectively treat PJIs. High-dose ALBC has become the gold standard for the treatment of chronic PJIs, and multiple studies have shown ALBC to be effective in eradicating infections [3,9–11]. However, the effectiveness of low-dose ALBC (<2 g per 40-g batch) as prophylaxis is more controversial.
Effect of Antibiotic-Impregnated Bone Cement in Primary Total Knee Arthroplasty
2019, Journal of ArthroplastyThe Economics of Antibiotic Cement in Total Knee Arthroplasty: Added Cost with No Reduction in Infection Rates
2019, Journal of ArthroplastySuccess rates, characteristics, and costs of articulating antibiotic spacers for total knee periprosthetic joint infection
2017, KneeCitation Excerpt :There are currently few Food and Drug Administration (FDA) approved premixed cements available in the United States, and the doses (0.5–1.0 g of aminoglycoside antibiotic per 40 g of cement) of antibiotic in these cements are limited [22]. This has led surgeons to create their own antibiotic cement mixtures intraoperatively, producing a variable final product [1,23]. Commercially available prefabricated spacers, intraoperative spacer molds, and a variety of different intraoperatively created static and articulating antibiotic spacer constructs have been described in the literature.
Biocompatible Coating
2014, Comprehensive Materials Processing
Supported in part by EM Industries, Hawthorne, NY.